Segment Reporting (Tables)

12 Months Ended

Feb. 27, 2016

Segment Reporting

Schedule of reconciliation of the company's business segments to the condensed consolidated financial statements

	Retail Pharmacy		Pharmacy Services		Intersegment Eliminations(1)			Consolidated
February 27, 2016:
Revenues	$	26,865,931	$	4,103,513	$	(232,787	)	$	30,736,657
Gross Profit		7,595,429		230,826		—			7,826,255
Adjusted EBITDA(2)		1,300,905		101,357		—			1,402,262
February 28, 2015:
Revenues	$	26,528,377	$	—	$	—		$	26,528,377
Gross Profit		7,576,732		—		—			7,576,732
Adjusted EBITDA(2)		1,322,843		—		—			1,322,843
March 1, 2014:
Revenues	$	25,526,413	$	—	$	—		$	25,526,413
Gross Profit		7,323,734		—		—			7,323,734
Adjusted EBITDA(2)		1,324,959		—		—			1,324,959

(1)	Intersegment eliminations include intersegment revenues and corresponding cost of revenues that occur when Pharmacy Services segment customers use Retail Pharmacy segment stores to purchase covered products. When this occurs, both the Retail Pharmacy and Pharmacy Services segments record the revenue on a stand-alone basis.
(2)	See "Adjusted EBITDA, Adjusted Net Income, Adjusted Net Income per Diluted Share and Other Non-GAAP Measures" in MD&A for additional details.

Schedule of reconciliation of net income to Adjusted EBITDA

	February 27, 2016 (52 weeks)			February 28, 2015 (52 weeks)			March 1, 2014 (52 weeks)
Net income	$	165,465		$	2,109,173		$	249,414
Interest expense		449,574			397,612			424,591
Income tax expense		139,297			158,951			161,883
Income tax valuation allowance reduction		(26,358	)		(1,841,304	)		(161,079	)
Depreciation and amortization expense		509,212			416,628			403,741
LIFO charge (credit)		11,163			(18,857	)		104,142
Lease termination and impairment charges		48,423			41,945			41,304
Loss on debt retirements, net		33,205			18,512			62,443
Other		72,281			40,183			38,520
Adjusted EBITDA	$	1,402,262		$	1,322,843		$	1,324,959

Schedule of reconciliation of balance sheet information for the Company's reportable segments

	Retail Pharmacy		Pharmacy Services		Eliminations(2)			Consolidated
February 27, 2016:
Total Assets	$	8,468,186	$	2,948,548	$	(139,724	)	$	11,277,010
Goodwill		76,124		1,637,351		—			1,713,475
Additions to property and equipment and intangible assets		667,719		2,276		—			669,995
February 28, 2015:
Total Assets	$	8,777,425	$	—	$	—		$	8,777,425
Goodwill		76,124		—		—			76,124
Additions to property and equipment and intangible assets		539,386		—		—			539,386

(2)           Intersegment eliminations include netting of the Pharmacy Services segment long-term deferred tax liability of $116,027 against the Retail Pharmacy segment long-term deferred tax asset for consolidation purposes in accordance with ASC 740, and intersegment accounts receivable of $23,697, as of February 27, 2016, that represents amounts owed from the Pharmacy Services segment to the Retail Pharmacy segment that are created when Pharmacy Services segment customers use Retail Pharmacy segment stores to purchase covered products.